Rimidi to Showcase New Chronic Kidney Disease Module at HLTH 2023, Complementing Suite of Chronic Disease Management Solutions

News | October 3rd, 2023

The new module will provide care teams with better visibility into patient data, improving management for patients with Chronic Kidney Disease

ATLANTA – October 3, 2023 – Rimidi, a leading clinical management platform designed to optimize clinical workflows, enhance patient experiences, and achieve quality objectives for chronic disease management, today announced the launch of its new Chronic Kidney Disease (CKD) Module, designed to give providers better visibility on the status of their population of patients with CKD to improve disease management.

Kidney diseases are one of the leading causes of death in the U.S. today, and comorbidities such as diabetes and high blood pressure are the primary cause of kidney failure – currently responsible for 3 out of 4 new cases of kidney failure. As a result, proactively managing CKD is critical.

Similar to Rimidi’s additional chronic disease modules, the CKD Module will combine clinically relevant data from the Electronic Health Record (EHR) with patient-generated data from connected devices and patient surveys into a streamlined, problem-oriented view that allows for better risk stratification and chronic disease management.

Specifically, Rimidi’s CKD Module:

  • Allows clinicians to visualize a consolidated view of relevant diagnoses, medications, lab results, risk scores and current treatment modalities such as dialysis on one screen, within their EHR workflow.
  • Presents a Kidney Failure Risk Equation (KFRE) based on data ingested from the EHR. The KFRE predicts the 5-year risk of end-stage renal disease (ESRD) in patients with chronic kidney disease (CKD) stages 3-5.
  • Enables providers to address gaps in care versus practice guidelines and triage CKD patients’ needs with population-level risk stratification tools.

“Given that Rimidi already supports disease management and remote patient monitoring for diabetes and hypertension, two common risk factors for CKD, developing a full CKD Module was a natural platform progression,” said Lucienne Ide, MD, PhD, Founder and CEO of Rimidi. “As we continue to see innovations in connected devices and systems for treating and assessing CKD progression, being able to analyze and interpret all relevant data in a unified platform will drive clinical efficiency, coordination, and positive impact for CKD patients.”

In 2024, Rimidi plans to integrate additional data from connected medical devices used in renal care to further support patient-centered and data-driven care delivery.

For more information about Rimidi’s Chronic Kidney Disease Module, visit rimidi.com/chronic-kidney-disease or stop by booth #853 at HLTH 2023.

About Rimidi
Created by doctors, for doctors, Rimidi is a digital health company that supports healthcare providers in the delivery of remote patient monitoring and chronic disease management with EHR-integrated software, services, and connected devices. By combining clinical data from the EHR with data from connected devices and patient surveys, Rimidi presents a complete picture of the patient and supports care delivery across the continuum from the clinic to the home to allow for proactive, guideline-based management and prioritization of highest-need patients. visit rimidi.com and follow us on X, formerly known as Twitter and LinkedIn.

Media Contact:
Michelle Rand
Alloy, on behalf of Rimidi